Tags

Type your tag names separated by a space and hit enter

Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Anticancer Res. 1996 Nov-Dec; 16(6C):3997-4000.AR

Abstract

The incidence of breast disorders, in a series of 142 women of reproductive age who received combined oral contraception (OC) for birth control and in 98 postmenopausal women who received hormone replacement therapy (HRT) with estrogens and progestins, for seven years, was compared with control groups. A lower incidence of benign breast diseases was observed among OC users (p < 0.001) and HRT recipients (p < 0.001). No differences were observed in the incidence of breast cancer among the groups studied. OC use and HRT do not increase the risk for breast cancer and decrease the incidence of benign breast diseases.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, University of Patras, Rio, Greece.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9042326

Citation

Tzingounis, V, et al. "Incidence of Benign and Malignant Breast Disorders in Women Taking Hormones (contraceptive Pill or Hormonal Replacement Therapy)." Anticancer Research, vol. 16, no. 6C, 1996, pp. 3997-4000.
Tzingounis V, Cardamakis E, Ginopoulos P, et al. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy). Anticancer Res. 1996;16(6C):3997-4000.
Tzingounis, V., Cardamakis, E., Ginopoulos, P., & Argiropoulos, G. (1996). Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy). Anticancer Research, 16(6C), 3997-4000.
Tzingounis V, et al. Incidence of Benign and Malignant Breast Disorders in Women Taking Hormones (contraceptive Pill or Hormonal Replacement Therapy). Anticancer Res. 1996 Nov-Dec;16(6C):3997-4000. PubMed PMID: 9042326.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy). AU - Tzingounis,V, AU - Cardamakis,E, AU - Ginopoulos,P, AU - Argiropoulos,G, PY - 1996/11/1/pubmed PY - 1996/11/1/medline PY - 1996/11/1/entrez KW - Biology KW - Breast Cancer KW - Cancer KW - Contraception KW - Contraceptive Agents KW - Contraceptive Agents, Estrogen KW - Contraceptive Agents, Female KW - Contraceptive Methods KW - Correlation Studies KW - Developed Countries KW - Diseases KW - Europe KW - Family Planning KW - Greece KW - Hormone Replacement Therapy KW - Incidence KW - Measurement KW - Mediterranean Countries KW - Neoplasms KW - Oral Contraceptives KW - Oral Contraceptives, Combined KW - Research Methodology KW - Risk Factors KW - Southern Europe KW - Statistical Studies KW - Studies KW - Treatment SP - 3997 EP - 4000 JF - Anticancer research JO - Anticancer Res. VL - 16 IS - 6C N2 - The incidence of breast disorders, in a series of 142 women of reproductive age who received combined oral contraception (OC) for birth control and in 98 postmenopausal women who received hormone replacement therapy (HRT) with estrogens and progestins, for seven years, was compared with control groups. A lower incidence of benign breast diseases was observed among OC users (p < 0.001) and HRT recipients (p < 0.001). No differences were observed in the incidence of breast cancer among the groups studied. OC use and HRT do not increase the risk for breast cancer and decrease the incidence of benign breast diseases. SN - 0250-7005 UR - https://www.unboundmedicine.com/medline/citation/9042326/Incidence_of_benign_and_malignant_breast_disorders_in_women_taking_hormones__contraceptive_pill_or_hormonal_replacement_therapy__ L2 - https://medlineplus.gov/breastcancer.html DB - PRIME DP - Unbound Medicine ER -